Meloxicam sodium salt hydrate

• Catalog No.: M3935
• CAS Number: 71125-39-8(anhydrous)
• M. F.: C14H14N3NaO5S2
• M. W.: 391.39783

SYNONYMS

• IUPAC name: sodium 2-methyl-3-[(5-methyl-1,3-thiazol-2-yl)carbamoyl]-1,1-dioxo-2H-1λ^6,2-benzothiazin-4-olate hydrate
• IUPAC Traditional name: sodium 2-methyl-3-[(5-methyl-1,3-thiazol-2-yl)carbamoyl]-1,1-dioxo-1λ^6,2-benzothiazin-4-olate hydrate
• Synonyms: Mobec sodium salt hydrate; Metacam sodium salt hydrate; 4-Hydroxy-2-methyl-N-(5-methyl-2-thiazolyl)-2H-1,2-benzothiazine-3-carboxamide 1,1-dioxide sodium hydrate; UH-AC 62XX sodium salt hydrate

DATABASE IDS

• CAS Number: 71125-39-8(anhydrous)
• MDL Number: MFCD11046047
• PubChem SID: 24278802

PROPERTIES

• Apperance: yellow
• Solubility: DMSO: soluble
• Solubility: H2O: soluble
• European Hazard Symbols: Harmful (Xn)
• RID/ADR: UN 2811 6.1/PG 3
• Risk Statements: 22-36/37/38
• Safety Statements: 26
• Hazard Class: 6.1
• UN Number: 2811
• Packing Group: 3
• German water hazard class: 3

DETAILS

Description (English)

Biochem/physiol Actions
Meloxicam, a member of the oxicam family, is a non-steroidal anti-inflammatory drug (NSAID) that shows 300-fold selectivity for cyclooxygenase-2 (COX-2) vs cyclooxygenase-1 (COX-1). Meloxicam has been shown to abolish thymulin-induced increases of cytokines and NGF in the liver of rats. Meloxicam also suppresses tumor growth and may be capable of antagonizing cachexia in vitro.